VECTUS BIOSYSTEMS
From 20 years of scientific observations of metabolic change as a result of salt intake, came the discovery by Dr Karen Duggan in 2003 that a naturally occurring molecule in the human body was capable of reversing fibrosis caused by hypertension and other chronic diseases such as diabetes. In 2005 Vectus Biosystems Limited was formed to take Dr Duggan’s discovery through to an orally deliverable drug.
VECTUS BIOSYSTEMS
Industry:
Biotechnology
Founded:
2005-01-01
Address:
Sydney, New South Wales, Australia
Country:
Australia
Website Url:
http://www.vectusbiosystems.com.au
Total Employee:
1+
Status:
Active
Contact:
+61288768200
Email Addresses:
[email protected]
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF WordPress Font Awesome Mobile Non Scaleable Content Apache Wordpress Plugins Contact Form 7
Similar Organizations
Arcion Therapeutics
Arcion Therapeutics is a biotechnology company developing treatments for chronic pain.
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.vectusbiosystems.com.au Semrush global rank: 13.1 M Semrush visits lastest month: 78
- Host name: 11.0.153.160.host.secureserver.net
- IP address: 160.153.0.11
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Vectus Biosystems"
Vectus Biosystems
Vectus Biosystems Limited intends to remain a research and development company, and license its current and future technologies.See details»
About Us - Vectus Biosystems
In 2005 Vectus Biosystems Limited was formed to take Dr Duggan’s discovery through to an orally deliverable drug. Today, Vectus Biosystems Limited holds patents around the …See details»
Vectus
Vectus' lead compound, VB0004 is aimed at addressing two significant health challenges in a single therapeutic – these are the functional dimension of organ fibrosis, which is the …See details»
Vectus Biosystems Company Profile - Office Locations ... - Craft
Oct 14, 2024 · Its lead compound, VB0004, has potent anti-hypertensive properties as well as anti-fibrotic activity in the heart and kidneys. See insights on Vectus Biosystems including …See details»
Vectus Biosystems - LinkedIn
Vectus Biosystems Limited (ASX:VBS) is developing a treatment for fibrosis and high blood pressure, which includes the treatment for three of the largest diseases in the fibrotic market, …See details»
Vectus Biosystems - Crunchbase Company Profile & Funding
Vectus Biosystems is located in Sydney, New South Wales, Australia. Who are Vectus Biosystems's competitors? Alternatives and possible competitors to Vectus Biosystems may …See details»
Vectus Biosystems Limited - Company Profile Report - IBISWorld
Jun 30, 2023 · Vectus Biosystems Limited, is a locally-owned, publicly-listed company, engaged medical research and development. The company operates in New South Wales, and is …See details»
Company Vectus Biosystems Limited - MarketScreener.com
Sep 15, 2001 · Vectus Biosystems Limited is an Australia-based drug discovery and development company. The Company focuses on medical research and development. It is engaged in …See details»
Vectus Biosystems Company Description - Stock Analysis
Nov 8, 2024 · Company profile for Vectus Biosystems Limited (ASX: VBS) with a description, list of executives, contact details and other key facts.See details»
Vectus Biosystems - PitchBook
Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company has developed and patented various novel compounds for the treatment of chronic …See details»
Contact Us - Vectus Biosystems
E-mail Us: [email protected]. Vectus Biosystems Limited | ABN 54 117 526 137 | ...See details»
Vectus Biosystems - Overview, News & Similar companies
Feb 25, 2023 · View Vectus Biosystems (www.vectusbiosystems.com.au) location in New South Wales, Australia , revenue, industry and description. Find related and similar companies as …See details»
Vectus Biosystems Ltd. Company Profile | StatInvestor
Http://www.vectusbiosystems.com.au : Updated: 07/08/2019: Vectus Biosystems Ltd. is a drug discovery and development company. It is developing a treatment for fibrosis and high blood …See details»
Vectus Biosystems Ltd, VBS:ASX profile - FT.com - Financial Times
Nov 8, 2024 · Vectus Biosystems Ltd (VBS:ASX) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.See details»
Technology - Vectus Biosystems
Vectus Biosystems Limited is a drug discovery and development company based in North Ryde, Sydney. Using its platform technology, Vectus has constructed a library of more than 200 …See details»
Vectus Biosystems - VentureRadar
Vectus Biosystems Limited is a drug discovery and development company based in North Ryde, Sydney. Using its platform technology, Vectus has constructed a library of more than 200 …See details»
Organization: Vectus Biosystems - Cbonds.com
Organization name. Vectus Biosystems Limited. Country name. Australia Country of registration-Industry. Pharmaceutical Preparation and Biotechnology. Bond debt - ...See details»
Vectus Biosystems progresses clinical trials of drug VB0004 for ...
Vectus is now moving to first-in-human, phase 1b trials of VB-0004 on patients with mild to moderate hypertension with low cardio-vascular risk. From a drug ‘library’ of 1,000 …See details»
Vectus Biosystems » 2021 Annual Report
2021 Annual Report 10/25/2021. Vectus Biosystems Limited | ABN 54 117 526 137See details»
Vectus Biosystems » Annual Reports
2013 Annual Report. Vectus Biosystems Limited | ABN 54 117 526 137 | Privacy PolicyPrivacy PolicySee details»